IL6 and COVID-19: A few of these molecules have been translated to COVID-19 treatment, as for instance anti IL-6 monoclonal antibodies, anti-JAK1/2 small molecule inhibitors, both approved by national and international drug regulatory agencies for treating autoimmune conditions such as rheumatoid arthritis [147,148].